Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Rani Therapeutics Holdings Inc shares valued at $29,993 were purchased by McKinley Kate on Dec 13 ’24. At $1.67 per share, McKinley Kate acquired 17,960 shares. The insider’s holdings grew to 17,960 shares worth approximately $25862.399999999998 following the completion of this transaction.
Also, Imran Talat purchased 10,296 shares, netting a total of over 19,974 in proceeds. Following the buying of shares at $1.94 each, the insider now holds 494,751 shares.
Before that, South Cone Investments Limited had sold 3,829,360 shares from its account. In a trade valued at $10,141,674, the 10% Owner traded Rani Therapeutics Holdings Inc shares for $2.65 each. Upon closing the transaction, the insider’s holdings decreased to 3,829,360 shares, worth approximately $11.96 million.
As published in their initiating research note from Oppenheimer on August 02, 2024, Rani Therapeutics Holdings Inc [RANI] has been an Outperform and the price target has been revised to $17. Analysts at Maxim Group started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of June 13, 2024, Rodman & Renshaw has initiated its “Buy” rating for RANI.
Analyzing RANI Stock Performance
During the last five days, there has been a surge of approximately 3.60%. Over the course of the year, Rani Therapeutics Holdings Inc shares have jumped approximately 5.11%. Shares of the company reached a 52-week high of $1.6100 on 01/03/25 and a 52-week low of $1.2400 on 01/13/25. A 50-day SMA is recorded $1.5721, while a 200-day SMA reached $3.0552. Nevertheless, trading volume fell to 6.85 million shares from 0.1 million shares the previous day.
Support And Resistance Levels for Rani Therapeutics Holdings Inc (RANI)
According to the 24-hour chart, there is a support level at 1.3833, which, if violated, would cause prices to drop to 1.3267. In the upper region, resistance lies at 1.4733. The next price resistance is at 1.5067. RSI (Relative Strength Index) is 49.12 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0150, which suggests the price will decrease in the coming days. Percent R is at 32.01%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
